Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
venture capital (VC)
Biotech
Fierce Biotech Fundraising Tracker '26: Ollin, RQ Bio & more
Welcome to Fierce Biotech’s Fundraising Tracker for 2026.
Will Maddox
,
Darren Incorvaia
,
James Waldron
,
Gabrielle Masson
Jun 26, 2026 9:00am
Bionyra emerges with $165M and three licensed I&I assets
Jun 22, 2026 7:00am
Big Pharma-backed SonoThera sounds off with $125M series B
Jun 10, 2026 10:48am
How RA Capital is offering ‘Chinese clinical expertise in a box’
Jun 5, 2026 8:19am
Create Medicines fashions $122M raise for in vivo CAR-T dreams
May 14, 2026 9:42am
Private Swiss biotechs hit record funding in 2025
May 4, 2026 10:00pm
